These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 1324082
1. Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections. Masuo Y, Ohtaki T, Masuda Y, Tsuda M, Fujino M. Brain Res; 1992 Mar 13; 575(1):113-23. PubMed ID: 1324082 [Abstract] [Full Text] [Related]
2. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate. Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC. Endocrinology; 1996 Jul 13; 137(7):2815-22. PubMed ID: 8770902 [Abstract] [Full Text] [Related]
3. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states. Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M. Mol Pharmacol; 1996 Dec 13; 50(6):1596-604. PubMed ID: 8967982 [Abstract] [Full Text] [Related]
4. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H. Endocrinology; 1999 Mar 13; 140(3):1285-93. PubMed ID: 10067855 [Abstract] [Full Text] [Related]
5. Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Köves K, Arimura A, Görcs TG, Somogyvári-Vigh A. Neuroendocrinology; 1991 Aug 13; 54(2):159-69. PubMed ID: 1766552 [Abstract] [Full Text] [Related]
6. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking. Suda K, Smith DM, Ghatei MA, Murphy JK, Bloom SR. J Clin Endocrinol Metab; 1991 May 13; 72(5):958-64. PubMed ID: 1673686 [Abstract] [Full Text] [Related]
7. Regional distribution of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat central nervous system as determined by sandwich-enzyme immunoassay. Masuo Y, Suzuki N, Matsumoto H, Tokito F, Matsumoto Y, Tsuda M, Fujino M. Brain Res; 1993 Jan 29; 602(1):57-63. PubMed ID: 8095427 [Abstract] [Full Text] [Related]
9. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ. J Mol Neurosci; 2005 Jan 29; 25(3):215-24. PubMed ID: 15800375 [Abstract] [Full Text] [Related]
10. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation. Hashimoto H, Ogawa N, Hagihara N, Yamamoto K, Imanishi K, Nogi H, Nishino A, Fujita T, Matsuda T, Nagata S, Baba A. Mol Pharmacol; 1997 Jul 29; 52(1):128-35. PubMed ID: 9224822 [Abstract] [Full Text] [Related]
11. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB, Niewiadomski P, Nowak JZ. Gen Comp Endocrinol; 2004 Jun 29; 137(2):187-95. PubMed ID: 15158130 [Abstract] [Full Text] [Related]
12. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. Buscail L, Gourlet P, Cauvin A, De Neef P, Gossen D, Arimura A, Miyata A, Coy DH, Robberecht P, Christophe J. FEBS Lett; 1990 Mar 12; 262(1):77-81. PubMed ID: 2156735 [Abstract] [Full Text] [Related]
13. Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23. Vertongen P, Ciccarelli E, Woussen-Colle MC, De Neef P, Robberecht P, Cauvin A. Endocrinology; 1994 Oct 12; 135(4):1537-42. PubMed ID: 7925114 [Abstract] [Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta. Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C. Endocrinology; 2000 Mar 12; 141(3):1158-67. PubMed ID: 10698193 [Abstract] [Full Text] [Related]
16. Characterization and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites in the brain of the frog Rana ridibunda. Jeandel L, Yon L, Chartrel N, Gonzalez B, Fournier A, Conlon JM, Vaudry H. J Comp Neurol; 1999 Sep 20; 412(2):218-28. PubMed ID: 10441752 [Abstract] [Full Text] [Related]
18. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development. Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B. J Comp Neurol; 2000 Oct 02; 425(4):495-509. PubMed ID: 10975876 [Abstract] [Full Text] [Related]
19. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA. Cancer Res; 2000 Jun 01; 60(11):3105-12. PubMed ID: 10850463 [Abstract] [Full Text] [Related]
20. Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells. Moody TW, Zia F, Makheja A. Peptides; 1993 Jun 01; 14(2):241-6. PubMed ID: 8387187 [Abstract] [Full Text] [Related] Page: [Next] [New Search]